Target intelligence / Profile preview

Sodium-dependent phosphate transport protein 2C (SLC34A3)

Target
SLC34A3
Molecular classification
Transporter, Sodium-phosphate symporter, Solute carrier protein (SLC family: SLC34A3 subfamily)
01

Overview

Sodium-dependent phosphate transport protein 2C is an integral membrane transporter responsible for the reabsorption of inorganic phosphate in the kidney via sodium-coupled transport. It regulates local and systemic phosphate concentrations, supporting bone health, cellular metabolism, and energy production. Dysfunction or genetic mutations in this transporter (SLC34A3 gene) cause hereditary hypophosphatemic rickets with hypercalciuria, marked by phosphate wasting, rickets, and increased vitamin D levels. The protein is a member of the SLC34 family and primarily expressed in the renal proximal tubule, mediating 2 Na+:1 phosphate ion exchange. Its activity is fundamental for maintaining balance of phosphate and overall mineral metabolism

Other names
Na(+)-dependent phosphate cotransporter 2CSodium/inorganic phosphate cotransporter IICSodium/phosphate cotransporter 2CSolute carrier family 34 member 3SLC34A3NaPi-IIcNPT2C
02

Mechanism of action

Drugs or small molecules targeting Sodium-dependent phosphate transport protein 2C would exert action by modulating renal phosphate reabsorption (typically by inhibiting or enhancing transporter activity)

03

Biological functions

Phosphate homeostasisRenal phosphate reabsorptionMaintenance of body mineral balanceRegulation of inorganic phosphate concentration in kidney
04

Disease associations

Hereditary hypophosphatemic rickets with hypercalciuria (a genetically inherited disease characterized by renal phosphate wasting and rickets)Renal disorders associated with phosphate handling (e.g., hypophosphatemia, hypercalciuria)
05

Safety considerations

Therapeutic modulation of SLC34A3 could unintentionally disrupt phosphate homeostasis, potentially leading to hypophosphatemia, bone demineralization, nephrolithiasis, and abnormalities in calcium and vitamin D metabolism
06

Biomarkers

Genetic mutation and expression levels of SLC34A3 are biomarkers for hereditary hypophosphatemic rickets with hypercalciuriaDetection of renal phosphate wasting and serum phosphate levels in clinical diagnosis

Beyond the preview

Go deeper on Sodium-dependent phosphate transport protein 2C (SLC34A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent phosphate transport protein 2C (SLC34A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call